Better Coronavirus Stock: Moderna vs. VBI Vaccines
Moderna (NASDAQ: MRNA) has become a household name this year thanks to the rapid speed with which it has been developing and testing its COVID-19 vaccine candidate, mRNA-1273. The stock has also been a big winner, soaring more than 300% so far in 2020.
But it's far from the only company attempting to develop coronavirus vaccine, and one far less well-known biotech in the hunt has seen its share price climb almost as much as Moderna's. That biotech is VBI Vaccines (NASDAQ: VBIV).
Which of these two coronavirus-focused biotech stocks is the better pick for investors now? Here's how they stack up against each other.
Source Fool.com
